We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Syndrome drugs.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Syndrome drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Syndrome drugs Product List

1～15 item / All 15 items

Displayed results
[Research Material] Global Market for the Treatment of HIV-Related Lipodystrophy Syndrome

[Research Material] Global Market for the Treatment of HIV-Related Lipodystrophy Syndrome

Global Market for HIV-Related Lipodystrophy Syndrome Treatment: Specific Drug Treatments, Cosmetic Correction Treatments, Hospitals, Specialist Clinics, Others

This research report (Global HIV Associated Lipodystrophy Syndrome Treatment) investigates and analyzes the current state and outlook for the global market for HIV-associated lipodystrophy syndrome treatment over the next five years. It includes information on the overview of the global HIV-associated lipodystrophy syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on specific drug treatments and cosmetic corrective treatments, while the segments by application target hospitals, specialist clinics, and others. The regional segments calculate the market size for HIV-associated lipodystrophy syndrome treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in HIV-associated lipodystrophy syndrome treatment, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Asperger Syndrome Treatment Drugs

[Research Material] The Global Market for Asperger Syndrome Treatment Drugs

World Market for Asperger's Syndrome Treatment Drugs: Antipsychotics, Selective Serotonin Reuptake Inhibitors, Psychiatric Drugs, Others, Hospitals, Clinics, Diagnosis ...

This research report (Global Asperger Syndrome Drugs Market) investigates and analyzes the current status and outlook for the global market for Asperger syndrome treatment drugs over the next five years. It includes information on the overview of the global Asperger syndrome treatment drugs market, trends among major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include antipsychotics, selective serotonin reuptake inhibitors, psychiatric drugs, and others, while the segments by application focus on hospitals, clinics, diagnostic centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Asperger syndrome treatment drugs. The report also includes the market share of major companies in the Asperger syndrome treatment drugs sector, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Tourette Syndrome Treatment Drugs

[Research Material] Global Market for Tourette Syndrome Treatment Drugs

World Market for Tourette Syndrome Treatments: AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipa ...

This research report (Global Tourette Syndrome Drug Market) investigates and analyzes the current state and future outlook of the global market for Tourette syndrome treatment drugs over the next five years. It includes information on the overview of the global Tourette syndrome treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipam Hydrochloride, and Others, while the segments by application focus on research centers, hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Tourette syndrome treatment drugs. The report also includes the market share of major companies in the Tourette syndrome treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Short Bowel Syndrome (SBS) Therapeutics

[Research Material] Global Market for Short Bowel Syndrome (SBS) Therapeutics

World Market for Short Bowel Syndrome (SBS) Treatment Drugs: Glucagon-like Peptide-2 (GLP-2), Growth Hormone, Glutamine, Others, Hospitals, Clinics...

This research report (Global Short Bowel Syndrome (SBS) Drugs Market) investigates and analyzes the current status and outlook for the global market of drugs for treating short bowel syndrome (SBS) over the next five years. It includes information on the overview of the global short bowel syndrome (SBS) drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the short bowel syndrome (SBS) drug market by type include glucagon-like peptide-2 (GLP-2), growth hormone, glutamine, and others, while the segments by application focus on hospitals, clinics, and retail pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for short bowel syndrome (SBS) drugs. It also includes the market share of major companies in the short bowel syndrome (SBS) drug market, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Acute Respiratory Distress Syndrome Treatments

[Research Material] Global Market for Acute Respiratory Distress Syndrome Treatments

Global Market for Acute Respiratory Distress Syndrome Treatments: Methylprednisolone, Hydrocortisone, Injectable Bovine Lung Surfactant, Others, Hospitalized Patients ...

This research report (Global Acute Respiratory Distress Syndrome Therapeutics Market) investigates and analyzes the current state and outlook for the global market for acute respiratory distress syndrome therapeutics over the next five years. It includes information on the overview of the global acute respiratory distress syndrome therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the acute respiratory distress syndrome therapeutics market include methylprednisolone, hydrocortisone, injectable bovine lung surfactant, and others, while the segments by application focus on inpatients and outpatients. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acute respiratory distress syndrome therapeutics. It also includes the market share of major companies in the acute respiratory distress syndrome therapeutics market, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Irritable Bowel Syndrome Treatment

[Research Material] The Global Market for Irritable Bowel Syndrome Treatment

Global Market for Irritable Bowel Syndrome Treatment: Constipation-Predominant Irritable Bowel Syndrome, Diarrhea-Predominant Irritable Bowel Syndrome, Mixed Irritable Bowel Syndrome, Hospitals, Clinics, Home Healthcare Settings.

This research report (Global Irritable Bowel Syndrome Treatment Market) investigates and analyzes the current status and outlook for the global irritable bowel syndrome treatment market over the next five years. It includes information on the overview of the global irritable bowel syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the irritable bowel syndrome treatment market include constipation-predominant irritable bowel syndrome, diarrhea-predominant irritable bowel syndrome, and mixed irritable bowel syndrome. The segments by application focus on hospitals, clinics, and home healthcare settings. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for irritable bowel syndrome treatment. It also includes the market share of major companies in the irritable bowel syndrome treatment sector, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Myelodysplastic Syndromes (MDS)

[Research Material] The Global Market for Treatment of Myelodysplastic Syndromes (MDS)

World Market for Myelodysplastic Syndromes (MDS) Treatment: Azacitidine, Lenalidomide, Decitabine, Deferasirox, Monoclonal Dysplasia...

This research report (Global Myelodysplastic Syndrome (MDS) Treatment Market) investigates and analyzes the current status and outlook for the global market for myelodysplastic syndrome (MDS) treatment over the next five years. It includes information on the overview of the global myelodysplastic syndrome (MDS) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the myelodysplastic syndrome (MDS) treatment market by type include azacitidine, lenalidomide, decitabine, and deferasirox, while the segments by application focus on refractory cytopenia with unilineage dysplasia, refractory anemia with ringed sideroblasts, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for myelodysplastic syndrome (MDS) treatment. It also includes the market share of major companies in the myelodysplastic syndrome (MDS) treatment sector, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatments of Basal Cell Nevus Syndrome

[Research Material] Global Market for Treatments of Basal Cell Nevus Syndrome

Global Market for Treatments of Basal Cell Nevus Syndrome: Itraconazole, Patidegib Hydrochloride, REM-001, TG-1042, Trifarotene, ...

This research report (Global Basal Cell Nevus Syndrome Drug Market) investigates and analyzes the current state and future outlook of the global market for drugs treating basal cell nevus syndrome over the next five years. It includes information on the overview of the global basal cell nevus syndrome drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include itraconazole, patidegib hydrochloride, REM-001, TG-1042, trifarnone, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for basal cell nevus syndrome drugs. It also includes the market share of major companies in the basal cell nevus syndrome drug market, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Polycystic Ovary Syndrome Treatment

[Research Material] Global Market for Polycystic Ovary Syndrome Treatment

Global Market for Polycystic Ovary Syndrome Treatment: Oral Contraceptives, Insulin Sensitizers, Antidepressants, Ornithine Decarboxylase Inhibitors, Aromatase ...

This research report (Global Polycystic Ovary Syndrome Treatment Market) investigates and analyzes the current status and outlook for the global market for polycystic ovary syndrome treatment over the next five years. It includes information on the overview of the global polycystic ovary syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the polycystic ovary syndrome treatment market focus on oral contraceptives, insulin sensitizers, antidepressants, ornithine decarboxylase inhibitors, aromatase inhibitors, and diuretics, while the segments by application target hospital pharmacies and drugstores. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for polycystic ovary syndrome treatment. The report also includes the market share of major companies in the polycystic ovary syndrome treatment market, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Eosinophilia Syndrome Drugs

[Research Material] Global Market for Eosinophilia Syndrome Drugs

Eosinophilia syndrome drugs global market: Benralizumab, Dasatinib, Dexmethylphenidate hydrochloride, Mepolizumab, Others, Research centers ...

This research report (Global Hypereosinophilic Syndrome Drug Market) investigates and analyzes the current state and outlook for the global market of eosinophilia syndrome drugs over the next five years. It includes information on the overview of the global eosinophilia syndrome drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Benralizumab, Dasatinib, Dexamethasone, Mepolizumab, and others, while the segments by application focus on research centers, hospitals, and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for eosinophilia syndrome drugs. It also includes the market share of major companies in the eosinophilia syndrome drug market, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【Research Material】World Market for the Treatment of Time Zone Shift Syndrome

【Research Material】World Market for the Treatment of Time Zone Shift Syndrome

World Market for Treatment of Time Zone Syndrome: Prescription Drugs, OTC, Hospital Pharmacies, Retail Pharmacies, Online

This research report (Global Time Zone Change Syndrome Treatment Market) investigates and analyzes the current status and outlook for the global market for treating time zone change syndrome over the next five years. It includes information on the overview of the global time zone change syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the time zone change syndrome treatment market focus on prescription drugs and OTC, while the segments by application target hospital pharmacies, retail pharmacies, and online. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for time zone change syndrome treatment. It also includes the market share of major companies in the time zone change syndrome treatment sector, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for the Treatment of Postural Orthostatic Tachycardia Syndrome (POTS)

[Research Material] Global Market for the Treatment of Postural Orthostatic Tachycardia Syndrome (POTS)

Global Market for the Treatment of Postural Orthostatic Tachycardia Syndrome (POTS): Primary Form, Secondary Form, Hospitals, Clinics, Outpatient Surgical Centers, Research Institutes

This research report (Global Postural Orthostatic Tachycardia Syndrome) investigates and analyzes the current status and outlook for the global market for the treatment of Postural Orthostatic Tachycardia Syndrome (POTS) over the next five years. It includes information on the global market overview for POTS treatment, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the POTS treatment market by type include primary forms and secondary forms, while the segments by application focus on hospitals, clinics, outpatient surgical centers, and laboratories. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for POTS treatment. It also includes the market share of major companies in the POTS treatment sector, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Cytokine Release Syndrome Treatment

[Research Material] Global Market for Cytokine Release Syndrome Treatment

Global Market for Cytokine Release Syndrome Treatment: Oral, Intravenous, Hospital, Home Care, Specialty Clinics, Others

This research report (Global Cytokine Release Syndrome Treatment Market) investigates and analyzes the current state and outlook for the global market for cytokine release syndrome treatment over the next five years. It includes information on the overview of the global cytokine release syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cytokine release syndrome treatment market focus on oral and intravenous treatments, while the segments by application target hospitals, home care, specialty clinics, and others. The regional segments calculate the market size for cytokine release syndrome treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the cytokine release syndrome treatment sector, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Chronic Fatigue Syndrome Treatment Drugs

[Research Material] Global Market for Chronic Fatigue Syndrome Treatment Drugs

Global Market for Chronic Fatigue Syndrome Treatments: Analgesics & NSAIDs, Antidepressants & Antipsychotics, Antibiotics & Immunomodulators, Hospitals, Retail Pharmacies, Others

This research report (Global Chronic Fatigue Syndrome Drug Market) investigates and analyzes the current status and outlook for the global market of chronic fatigue syndrome treatment drugs over the next five years. It includes information on the overview of the global chronic fatigue syndrome treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include analgesics & NSAIDs, antidepressants & antipsychotics, and antibiotics & immunomodulators, while the segments by application focus on hospitals, retail pharmacies, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for chronic fatigue syndrome treatment drugs. The report also includes the market share of major companies in the chronic fatigue syndrome treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Asynchronous Syndrome Treatment

[Research Material] Global Market for Asynchronous Syndrome Treatment

Global Market for Asynchronous Syndrome Treatment: Prescription Drugs, OTC, Hospital Pharmacies, Retail Pharmacies, Online

This research report (Global Desynchronosis Treatment Market) investigates and analyzes the current state and outlook for the global market for desynchronosis treatment over the next five years. It includes information on the overview of the global desynchronosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the desynchronosis treatment market focus on prescription drugs and OTC, while the segments by application target hospital pharmacies, retail pharmacies, and online. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for desynchronosis treatment. It also includes the market share of major companies in desynchronosis treatment, product and business overviews, and sales performance.

  • Other services
  • Syndrome drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Syndrome drugs

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.